Omzo vs Regenics: Clinician Type, Pricing, and Medication Options
If you want a quick verdict: Omzo focuses on clinician-guided plans reviewed by licensed U.S. providers and offers compounded semaglutide starting at $179, while Regenics markets lower promotional entry pricing for semaglutide from $139 first month with renewals at $199 and is nurse-practitioner-led. This article compares Omzo vs Regenics across pricing, clinical oversight, medication sourcing, shipping, and extra offerings to help you decide.
Explore Omzo clinician-guided plans
Pricing and promotional structure
Price is one of the clearest differences in Omzo vs Regenics. Omzo lists semaglutide starting at $179 and tirzepatide starting at $279. Regenics advertises semaglutide at $139 for the first month and tirzepatide at $189 first month, with stated renewals of $199 and $279 respectively. Regenics notes that the lower amounts apply to the first month and that promotional pricing applies to the first month only.
See Regenics first-month pricing
Clinical oversight and prescribing model
Omzo vs Regenics differ in the clinician who reviews and prescribes care. Omzo describes clinician-guided plans reviewed by licensed U.S. providers and states clinical services are provided by third party networks of U.S.-licensed clinicians who determine eligibility and make final prescribing decisions. Regenics is described as nurse-practitioner-led GLP-1 care, with licensed nurse practitioners reviewing intake before anything is prescribed and overseeing every prescription.
Medication sourcing, regulatory notes, and fulfillment
Both providers offer compounded medications that are prepared by state-licensed compounding pharmacies and both include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Omzo explicitly states its compounded drugs are not FDA-approved and that it also may provide prescriptions for branded medications for patients to fill at their pharmacy. Regenics states its compounded medications are prepared by U.S. licensed compounding pharmacies and shipped free to your door and notes its pharmacy network is LegitScript certified.
Review Omzo medication options
Shipping, extras, and notable features
Omzo highlights fast, discreet delivery and says plans are FSA and HSA eligible. It also emphasizes that Omzo does not sell, dispense, or ship branded medications when prescriptions for branded products are written. Regenics advertises free shipping for medications compounded in the USA, no insurance required to start treatment, FSA and HSA eligibility, and an additional Sermorelin peptide therapy offering for recovery, energy, and muscle support.
Distinctive differences summarized
- Pricing format: Omzo lists starting prices; Regenics promotes a lower first-month price with higher renewal rates.
- Clinician type: Omzo uses licensed U.S. providers in third party networks; Regenics is nurse-practitioner-led.
- Medication handling: Both offer compounded medications not FDA-approved; Omzo may provide prescriptions for branded drugs but does not dispense them; Regenics highlights a LegitScript certified pharmacy network and free shipping.
- Extras: Regenics offers Sermorelin peptide therapy; Omzo emphasizes clinician-guided plans and discreet shipping.
| Criteria | Omzo | Regenics |
|---|---|---|
| Starting semaglutide price | $179 starting | $139 first month |
| Renewal pricing | Not specified in captured evidence | Renews at $199/mo for semaglutide per captured FAQ |
| Clinician oversight | Licensed U.S. providers in third party networks | Licensed nurse practitioners oversee prescriptions |
| Compounded meds regulatory note | Compounded meds not FDA-approved | Compounded meds not FDA-approved |
| Shipping | Fast, discreet delivery | Free shipping for compounded medication in the USA |
| Extra therapies | May prescribe branded meds; does not sell or ship branded meds | Sermorelin peptide therapy available |
Check Regenics program details
How to weigh Omzo vs Regenics
Choose based on whether initial cost, clinician type, or extra therapies matter most to you. If first-month promotional price and a Sermorelin option are priorities, Regenics documents a lower first-month fee and that peptide add-on. If you prefer plans described as clinician-guided with licensed U.S. providers and the option that a provider may write prescriptions for branded medications for you to fill, Omzo is presented that way in the captured evidence. Both providers state compounded medications are not FDA-approved, and both require clinician review to determine medical appropriateness.
Choose Omzo if…
Choose Omzo if you want clinician-guided plans reviewed by licensed U.S. providers, value the option that a provider may write a prescription for branded medications to fill at your pharmacy, and are comfortable with compounded semaglutide starting at $179 and compounded tirzepatide starting at $279 per the captured evidence.
Choose Regenics if…
Choose Regenics if a lower promotional first-month semaglutide price of $139 and a nurse-practitioner-led model with free shipping and an available Sermorelin peptide option better match your priorities, keeping in mind promotional pricing applies to the first month and renewals are stated to be higher.
Primary keyword: Omzo vs Regenics. Both platforms offer compounded GLP-1 care subject to clinician review and note compounded medications are not FDA-approved. Confirm eligibility, state availability, exact pricing, renewal terms, and shipping details with each provider before enrollment because details captured here may change.